Sibo-Ease | 120 Capsules | Enzyme Prebiotic Formulation For Biofilm And Gastrointestinal Support
|
상품가격 상세보기
이벤트보기
|
- 상품상세정보
상품특징
A unique enzyme formulation designed to disrupt the biofilm matrixSupport normal gastrointestinal function and microfloraDeveloped using in vitro testing of antibiofilm activitySignificant antibiofilm activity resulting in meaningful degradation of biofilm communities
상품설명
Biofilm consists of microorganisms encased within a self-produced matrix of exopolysaccharides and exoproteins that strongly adheres to interfaces and resists dislodgement. Microorganisms residing within biofilms are highly resistant to antimicrobials including antibiotics and bacteriocins produced by probiotics. Sibo-Ease is a unique enzyme formulation especially designed to disrupt the biofilm matrix that embeds potential gastrointestinal pathogens. Enzymes in Sibo-Ease are selected for their ability to lyse the extracellular polymers commonly found in biofilm as well as degrade bacterial and yeast cell wall structures. Sibo-Ease was developed using in vitro testing of antibiofilm activity and was found to have significant antibiofilm activity resulting in meaningful degradation of biofilm communities of potentially pathogenic bacteria and yeast. Sibo-Ease is intended for use in conjunction with efforts to support normal gastrointestinal function and microflora. As an adjunct to other efforts to eliminate potential pathogens, it is best combined with use of a high-potency, broad, multispecies probiotic formulation and a prebiotic to encourage the formation of healthy intestinal microbial biofilm communities. It may also be combined with antimicrobial agents. The capsules should be taken away from meals to maximize the enzyme effects.
A unique enzyme formulation designed to disrupt the biofilm matrixSupport normal gastrointestinal function and microfloraDeveloped using in vitro testing of antibiofilm activitySignificant antibiofilm activity resulting in meaningful degradation of biofilm communities
상품설명
Biofilm consists of microorganisms encased within a self-produced matrix of exopolysaccharides and exoproteins that strongly adheres to interfaces and resists dislodgement. Microorganisms residing within biofilms are highly resistant to antimicrobials including antibiotics and bacteriocins produced by probiotics. Sibo-Ease is a unique enzyme formulation especially designed to disrupt the biofilm matrix that embeds potential gastrointestinal pathogens. Enzymes in Sibo-Ease are selected for their ability to lyse the extracellular polymers commonly found in biofilm as well as degrade bacterial and yeast cell wall structures. Sibo-Ease was developed using in vitro testing of antibiofilm activity and was found to have significant antibiofilm activity resulting in meaningful degradation of biofilm communities of potentially pathogenic bacteria and yeast. Sibo-Ease is intended for use in conjunction with efforts to support normal gastrointestinal function and microflora. As an adjunct to other efforts to eliminate potential pathogens, it is best combined with use of a high-potency, broad, multispecies probiotic formulation and a prebiotic to encourage the formation of healthy intestinal microbial biofilm communities. It may also be combined with antimicrobial agents. The capsules should be taken away from meals to maximize the enzyme effects.
2019-04-13 14:11:22